You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 11, March 16, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Venous Thromboembolism
 •Women's Health, Other
 •Alert me on articles by topic

Estrogen Plus Progestin and Risk of Venous Thrombosis—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Dr Scarabin and colleagues raise the possibility that transdermal and oral estrogens differ in their association with venous thrombosis. In their case-control study of venous thromboembolism, 30 cases and 93 controls used transdermal estrogen, and no association of transdermal therapy with thrombosis was found.1 This study, as well as all others addressing this question, included only hospitalized women with idiopathic thrombosis and without a history of coronary heart disease and other illnesses. The 3 other published studies had small numbers of users, but all suggested a 2-fold increased thrombosis risk with transdermal estrogen.2-4

We maintain that the data on transdermal estrogen and thrombosis risk are inconclusive. Given that millions of women might want to use transdermal therapy for treatment of menopausal symptoms, data from large studies on the safety of transdermal therapy are indeed needed. At present, we lack sufficient evidence that transdermal estrogen is a safe . . . [Full Text of this Article]

Mary Cushman, MD, MSc
mary.cushman@uvm.edu
University of Vermont College of Medicine
Burlington

Ross Prentice, PhD
Fred Hutchinson Cancer Research Center
Seattle, Wash

Bruce M. Psaty, MD, PhD
University of Washington
Seattle

Frits R. Rosendaal, MD, PhD
Leiden University Medical Center
Leiden, the Netherlands

for the WHI Investigators


RELATED ARTICLES

Estrogen Plus Progestin and Risk of Venous Thrombosis
Pierre-Yves Scarabin, Emmanuel Oger, Tabassome Simon, and Geneviève Plu-Bureau
JAMA. 2005;293(11):1322.
EXTRACT | FULL TEXT  

Estrogen Plus Progestin and Risk of Venous Thrombosis
Richard E. Blackwell
JAMA. 2005;293(11):1322.
EXTRACT | FULL TEXT  

Estrogen Plus Progestin and Risk of Venous Thrombosis
Mary Cushman, Lewis H. Kuller, Ross Prentice, Rebecca J. Rodabough, Bruce M. Psaty, Randall S. Stafford, Steven Sidney, Frits R. Rosendaal, and for the Women’s Health Initiative Investigators
JAMA. 2004;292(13):1573-1580.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.